Article
CYP2C19 genotyping combined with on-clopidogrel platelet reactivity in predicting major adverse cardiovascular events in Chinese patients with percutaneous coronary intervention.
Thrombosis research - 1 Nov 2016
Tang Xiao-Fang, Han Ya-Ling, Zhang Jia-Hui, Wang Jing, Yao Yi, He Chen, Xu Bo, Gao Zhan, Qiao Shu-Bin, Chen Jue, Wu Yuan, Chen Ji-Lin, Gao Run-Lin, Yang Yue-Jin, Yuan Jin-Qing
Abstract excerpt
INTRODUCTION: Both CYP2C19 genotyping and platelet function testing are used to predict major adverse cardiac events (MACEs) in Chinese patients treated with clopidogrel and undergoing stent implantation, but the most accurate prognostic technique is still debated. Here, we combine both techniques, to determine if a more accurate prognosis is possible. METHODS: Patients undergoing stent implantation (1104) were...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.